AIDS and barriers

  • A. Mills

Abstract

It is vital to understand the precise mechanisms by which human immunodeficiency virus (HIV) transmission occurs to enable us to adopt measures to prevent its transmission. Prevention is at the moment the only weapon we have against AIDS. Our understanding of transmission by sexual activity which results in the exchange of body fluids and ways of preventing spread in this way is limited and oversimplistic.

Keywords

Obesity Syringe Dine Retro Virus Benzalkonium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fischl MA, Dickinson GM, Scott GB, Klimas N, Fletcher MA, Parks W. Evaluation of heterosexual partners, children and household contacts of adults with AIDS. JAMA 1987; 257: 640.PubMedCrossRefGoogle Scholar
  2. 2.
    Groopman JE, Sarngadharan MA, Salahuddin SZ, Buxbaum R, Huberman MS, Kinniburgh J, Sliski A, McLane MF, Essex M, Gallo RC. Apparent transmission of human-T-cell leukaemia virus type-III to a heterosexual woman with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102: 63–66.PubMedGoogle Scholar
  3. 3.
    Harris C, Small CB, Klein RS, Friedland GH, Moll B, Emeson EE, Spigland I, Steigbigel WH. Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med 1983; 308: 1181–1184.PubMedCrossRefGoogle Scholar
  4. 4.
    Peterman TA, Rand L, Stoneburner MD, Allen JR, Jaffe HW, Curran JW. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 1988; 259: 55–58.PubMedCrossRefGoogle Scholar
  5. 5.
    Stewart GJ, Tyler JPP, Cunningham AL, Barr JA, Driscoll GL, Gold J, Lamont BJ. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor Lancet 1985; 2: 581–585.PubMedCrossRefGoogle Scholar
  6. 6.
    Wofsy CB, Cohen JB, Hauer LB, Padian NS, Michaelis BA, Evans LA, Levy JA. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986; 1: 527–529.PubMedCrossRefGoogle Scholar
  7. 7.
    Biggar RJ. The AIDS problem in Africa. Lancet 1986; 1: 79–83.PubMedCrossRefGoogle Scholar
  8. 8.
    Chamberland M, White C, Lifson A, Danders TJ. AIDS in heterosexual contacts, a small but increasing number of cases. Paper presented at the Third International Conference on AIDS, Washington. 1987.Google Scholar
  9. 9.
    Editorial. AIDS and sex. Lancet 1988; 1: 31.Google Scholar
  10. 10.
    Winkelstein W, Samuel M, Padian NS, Wiley JA. Selected practices of San Francisco heterosexual men and the risk of infection by the human immunodeficiency virus. JAMA 1987; 257: 11.Google Scholar
  11. 11.
    Goedert JJ, Biggar RJ, Winn DM, Mann DL, Byar DP, Strong DM, DiGioia RA, Grossman RJ, Sanchez WC, Kase RG, et al. Decreased helper T-lymphocytes in homosexual men: sexual practices. Am J Epidemiol 1985; 122: 637–644.CrossRefGoogle Scholar
  12. 12.
    Fultz PN, McClure HM, Daugharty H, Brodie A, McGrath CR, Swenson B, Francis DP. Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis 1986; 154: 896–900.PubMedCrossRefGoogle Scholar
  13. 13.
    Conant M, Hardy D, Sernatinger J, Spicer D, Levy JA. Condoms prevent transmission of AIDS-associated retroviruses. JAMA 1986; 255: 1706.PubMedCrossRefGoogle Scholar
  14. 14.
    Eglin RP. Nonoxynol-9 pessaries and eondoms prevent transmission of HI V in vitro. B J Sexual Med; In press.Google Scholar
  15. 15.
    Wigersma L, Oud R. Safety and acceptability of condoms for use by homosexual men as a prophylactic against transmission of HIV during anogenital sexual intercourse. Br Med J 1987; 295: 94.CrossRefGoogle Scholar
  16. 16.
    Glass R, Vessey M, Wiggins P. Use-effectivemess of the condom in a selected family planning clinic population in the United Kingdom. Contraception 1974; 10: 591–598.PubMedCrossRefGoogle Scholar
  17. 17.
    Grady WR, Hayward MD, Yagi J. Contraceptive failure in the United States: estimates for the 1982 National Survey of Family Planning Growth. Fam Plann Perspect 1986; 18: 200–209.PubMedCrossRefGoogle Scholar
  18. 18.
    Editorial. Sheaths no barrier. New Scientist 1987; 1548: 12.Google Scholar
  19. 19.
    Johnson V, Masters W, Cramer Lewis K, In: Manual of family planning and contraceptive practice. Ed. ML Calderone. Baltimore: Williams and Wilkins, 1974; pp.237–238.Google Scholar
  20. 20.
    Hicks DR, Martin LS, Getchell JP, Heath JL, Francis DP, McDougal JS, Curran JW, Voeller B. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet 1985; 2: 1422.PubMedCrossRefGoogle Scholar
  21. 21.
    Sharman D, Chantier E, Dukes M, Hutchinson FG, Elstein M. Comparison of the action of nonosynol-9 and chlorhexidine on sperm. Fertil Steril 1986; 45: 259–264.PubMedGoogle Scholar
  22. 22.
    AIDS (Acquired Immune Deficiency Syndrome) and family planning and well woman services. Provisional guidelines from the Family Planning Association and the National Association of Family Planning Doctors. London: Family Planning Association, 1987: pp.1–9.Google Scholar
  23. 23.
    Soutter W, Turner MJ, White JO. Effects of human seminal plasma on the lymphocyte response to viral infection. In: AIDS and obstetrics and gynaecology. Proceedings of the 19th RCOG Study Group. London: Royal College of Obstetricians and Gynaecologists/Springer-Verlag, 1988. pp.49–57.Google Scholar
  24. 24.
    Alexander NJ, Anderson DJ. Immunology of semen. Fertil Steril 1987; 47: 192–205.PubMedGoogle Scholar
  25. 25.
    James K, Hargreave JR. Immunosuppression by seminal plasma and its possible clinical significance. Immunology Today 1984; 5: 357–363.CrossRefGoogle Scholar

Copyright information

© The Royal College of Obstetricians and Gynaecologists 1988

Authors and Affiliations

  • A. Mills

There are no affiliations available

Personalised recommendations